The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …

This international consensus statement is the collaborative effort of three medical societies
representing electrophysiology in North America, Europe and Asian-Pacific area: the Heart …

Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …

The Japanese Circulation Society (JCS) published the “Guidelines for Pharmacological
Treatment of Arrhythmia” in 2004, and a revised edition was published in 2009. 1 Both …

Sudden cardiac death (SCD) associated with athletic activity is a rare but devastating event.
Victims are usually young and apparently healthy, and while many of these deaths remain …

HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients
with inherited primary arrhythmia syndromes | EP Europace | Oxford Academic Skip to Main …

NSAT Non-sustained atrial tachycardia NSVT Non-sustained ventricular tachycardia PD
Pharmacodynamic P-GP P-glucoprotein PK Pharmacokinetic PM Pacemaker PVT …

This international consensus statement of the European Heart Rhythm Association (EHRA),
Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society is intended to provide …

Purpose Genetic testing has advanced significantly since the publication of the 2011
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the …

This international multidisciplinary expert consensus statement is intended to provide
comprehensive guidance that can be referenced at the point of care to cardiac …